RxDoctor Payments Data

Raj Ballal, MD

Cardiovascular Disease · Edison, NJNPI 1386645638

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.6% of the total across 549 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 41 manufacturers, the largest accounting for just 17.3% — the pattern of someone who eats at a lot of different presentations. Among cardiovascular disease clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$26,033in general payments, 2019–2025

Across 549 payments — averaging $47.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$4K
  • AstraZeneca$3K
  • Medtronic$2K
  • Abiomed$2K
  • Boston Scientific$2K
  • Impulse Dynamics (USA) Inc.$2K
  • plus $11K from 35 others

What the payments were for

  • Consulting fees$1,0004%
  • Travel & lodging$2931%
  • Food & beverage$24,62595%
  • Education$1150%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,033 in reported general payments places this provider in the 90th percentile of 1,006 cardiovascular disease providers in New Jersey.

See all cardiovascular disease providers in New Jersey →

Medicare billing

Part B allowed, 2024
$164,229
Medicare patients
1,397
Services billed
2,847

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Edison

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →